 |
|
Clomipramine vs Desipramine Crossover Trial in Body Dysmorphic Disorder
Selective Efficacy of a Serotonin Reuptake Inhibitor in Imagined Ugliness
Eric Hollander, MD;
Andrea Allen, PhD;
Jee Kwon, BA;
Bonnie Aronowitz, PhD;
James Schmeidler, PhD;
Cheryl Wong, MD;
Daphne Simeon, MD
Arch Gen Psychiatry. 1999;56:1033-1039.
Background Body dysmorphic disorder (preoccupation with an imagined or slight defect in appearance) is a common and disabling disorder associated with high rates of delusional symptoms and suicide attempts. Although preliminary studies suggest that serotonin reuptake inhibitors may be effective for body dysmorphic disorder, to date no controlled treatment studies have been published.
Methods Forty patients were enrolled and 29 were randomized into a 16-week, double-blind, crossover-design study of clomipramine, a potent serotonin reuptake inhibitor, and active control desipramine, a selective norepinephrine reuptake inhibitor. Outcome measures included specific ratings of body dysmorphic disorder severity, delusionality, and functional impairment.
Results Clomipramine was superior to desipramine in the acute treatment of body dysmorphic disorder symptoms as measured by assessment of patients' obsessive preoccupation with perceived body defects, repetitive behaviors in response to this preoccupation, and global ratings of symptom severity. Treatment efficacy was independent of the presence or severity of comorbid diagnoses of obsessive-compulsive disorder, depression, or social phobia. Likewise, clomipramine was equally effective regardless of whether the patients had insight or held their dysmorphic misperception with delusional intensity. Clomipramine was also superior to desipramine in improving functional disability.
Conclusions Clomipramine is more effective than desipramine in the treatment of body dysmorphic disorder and is effective even among those patients who are delusional.
From the Department of Psychiatry and the Compulsive, Impulsive, and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY.
RELATED ARTICLE
Treating Imagined Ugliness
Katharine A. Phillips, Steven A. Rasmussen, and Lawrence H. Price
Arch Gen Psychiatry. 1999;56(11):1041-1042.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Body Dysmorphic Disorder: Treating an Underrecognized Disorder
Phillips et al.
Am. J. Psychiatry 2008;165:1111-1118.
FULL TEXT
A 12-Month Follow-Up Study of the Course of Body Dysmorphic Disorder
Phillips et al.
Am. J. Psychiatry 2006;163:907-912.
ABSTRACT
| FULL TEXT
Olanzapine Augmentation of Fluoxetine in Body Dysmorphic Disorder
PHILLIPS
Am. J. Psychiatry 2005;162:1022-1023.
FULL TEXT
Clinical Features and Treatment of Body Dysmorphic Disorder
Phillips
Focus 2005;3:179-183.
ABSTRACT
| FULL TEXT
Surgical Nonpsychiatric Medical Treatment of Patients With Body Dysmorphic Disorder
Phillips et al.
Focus 2005;3:304-309.
ABSTRACT
| FULL TEXT
Placebo-Controlled Study of Pimozide Augmentation of Fluoxetine in Body Dysmorphic Disorder
Phillips
Am. J. Psychiatry 2005;162:377-379.
ABSTRACT
| FULL TEXT
Change in Psychosocial Functioning and Quality of Life of Patients With Body Dysmorphic Disorder Treated With Fluoxetine: A Placebo-Controlled Study
Phillips and Rasmussen
Psychosomatics 2004;45:438-444.
ABSTRACT
| FULL TEXT
Treatment of Somatoform Disorders With St. John's Wort: A Randomized, Double-Blind and Placebo-Controlled Trial
Muller et al.
Psychosom. Med. 2004;66:538-547.
ABSTRACT
| FULL TEXT
Fluoxetine was safe and effective for body dysmorphic disorder
Rao
Evid. Based Ment. Health 2002;5:119-119.
FULL TEXT
A Randomized Placebo-Controlled Trial of Fluoxetine in Body Dysmorphic Disorder
Phillips et al.
Arch Gen Psychiatry 2002;59:381-388.
ABSTRACT
| FULL TEXT
Surgical and Nonpsychiatric Medical Treatment of Patients With Body Dysmorphic Disorder
Phillips et al.
Psychosomatics 2001;42:504-510.
ABSTRACT
| FULL TEXT
Prevalence of Body Dysmorphic Disorder in a Community Sample of Women
Otto et al.
Am. J. Psychiatry 2001;158:2061-2063.
ABSTRACT
| FULL TEXT
Cognitive-behavioural therapy for body dysmorphic disorder
Veale
Adv. Psychiatr. Treat. 2001;7:125-132.
FULL TEXT
A Serotonin Reuptake Inhibitor for Imagined Ugliness?
JWatch Psychiatry 2000;2000:14-14.
FULL TEXT
Treating Imagined Ugliness
Phillips et al.
Arch Gen Psychiatry 1999;56:1041-1042.
FULL TEXT
|
